135 related articles for article (PubMed ID: 37289478)
1. ERCC6L2 syndrome: attack of the TP53 clones.
Wlodarski MW
Blood; 2023 Jun; 141(23):2788-2789. PubMed ID: 37289478
[No Abstract] [Full Text] [Related]
2. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.
Baccelli F; Leardini D; Cerasi S; Messelodi D; Bertuccio SN; Masetti R
Ann Hematol; 2023 Apr; 102(4):699-705. PubMed ID: 36790458
[TBL] [Abstract][Full Text] [Related]
3. The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Hakkarainen M; Kaaja I; Douglas SPM; Vulliamy T; Dokal I; Soulier J; Larcher L; Peffault de Latour R; Leblanc T; Sicre de Fontbrune F; Siitonen T; Lohi O; Hellström-Lindberg E; Barbany G; Tesi B; Shimamura A; Beier F; Jackson S; Kuperman AA; Falik Zaccai T; Tamary H; Mecucci C; Capolsini I; Jahnukainen K; Salmenniemi U; Niinimäki R; Varilo T; Kilpivaara O; Wartiovaara-Kautto U
Blood; 2023 Jun; 141(23):2853-2866. PubMed ID: 36952636
[TBL] [Abstract][Full Text] [Related]
4. [Bone marrow failure and TP53 activating mutations].
Ito E
Rinsho Ketsueki; 2022; 63(9):1115-1125. PubMed ID: 36198537
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow failure syndrome caused by homozygous frameshift mutation in the ERCC6L2 gene.
Järviaho T; Halt K; Hirvikoski P; Moilanen J; Möttönen M; Niinimäki R
Clin Genet; 2018 Feb; 93(2):392-395. PubMed ID: 28815563
[TBL] [Abstract][Full Text] [Related]
6. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.
Tummala H; Kirwan M; Walne AJ; Hossain U; Jackson N; Pondarre C; Plagnol V; Vulliamy T; Dokal I
Am J Hum Genet; 2014 Feb; 94(2):246-56. PubMed ID: 24507776
[TBL] [Abstract][Full Text] [Related]
7. ERCC6L2-associated inherited bone marrow failure syndrome.
Shabanova I; Cohen E; Cada M; Vincent A; Cohn RD; Dror Y
Mol Genet Genomic Med; 2018 May; 6(3):463-468. PubMed ID: 29633571
[TBL] [Abstract][Full Text] [Related]
8. First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
Bandini P; Borràs N; Fernandez Mellid E; Martin-Fernandez L; Melero Valentín P; Comes N; Ramírez L; Cadahia Fernández P; Rodríguez Ruiz M; Perez Encinas MM; Vidal F; Corrales I
Br J Haematol; 2023 Nov; 203(4):e102-e107. PubMed ID: 37696499
[No Abstract] [Full Text] [Related]
9. Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic
Tummala H; Dokal AD; Walne A; Ellison A; Cardoso S; Amirthasigamanipillai S; Kirwan M; Browne I; Sidhu JK; Rajeeve V; Rio-Machin A; Seraihi AA; Duncombe AS; Jenner M; Smith OP; Enright H; Norton A; Aksu T; Özbek NY; Pontikos N; Cutillas P; Dokal I; Vulliamy T
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7777-7782. PubMed ID: 29987015
[TBL] [Abstract][Full Text] [Related]
10. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.
Toki T; Yoshida K; Wang R; Nakamura S; Maekawa T; Goi K; Katoh MC; Mizuno S; Sugiyama F; Kanezaki R; Uechi T; Nakajima Y; Sato Y; Okuno Y; Sato-Otsubo A; Shiozawa Y; Kataoka K; Shiraishi Y; Sanada M; Chiba K; Tanaka H; Terui K; Sato T; Kamio T; Sakaguchi H; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Kanno H; Miyano S; Kojima S; Ishiguro A; Sugita K; Kenmochi N; Takahashi S; Eto K; Ogawa S; Ito E
Am J Hum Genet; 2018 Sep; 103(3):440-447. PubMed ID: 30146126
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow failure with body deformities].
Hu XR; Zhang L; Zhao BB; Li Y; Li XX; Zhang FK; Zhao X
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):255-257. PubMed ID: 35405785
[No Abstract] [Full Text] [Related]
12.
Donadieu J; Delhommeau F
Blood; 2018 Jan; 131(4):376-377. PubMed ID: 29371207
[No Abstract] [Full Text] [Related]
13. [Clinical significance of clonal hematopoiesis and disease boundaries in bone marrow failure diseases].
Suzuki T
Rinsho Ketsueki; 2023; 64(6):474-481. PubMed ID: 37407470
[TBL] [Abstract][Full Text] [Related]
14. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia.
Weinzierl EP; Arber DA
Am J Clin Pathol; 2013 Jan; 139(1):9-29. PubMed ID: 23270895
[TBL] [Abstract][Full Text] [Related]
15. Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort.
Giri N; Stratton P; Savage SA; Alter BP
Blood; 2017 Oct; 130(14):1674-1676. PubMed ID: 28838890
[No Abstract] [Full Text] [Related]
16. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.
Armes H; Bewicke-Copley F; Rio-Machin A; Di Bella D; Philippe C; Wozniak A; Tummala H; Wang J; Ezponda T; Prosper F; Dokal I; Vulliamy T; Kilpivaara O; Wartiovaara-Kautto U; Fitzgibbon J; Rouault-Pierre K
Br J Haematol; 2022 Dec; 199(5):754-764. PubMed ID: 36156210
[TBL] [Abstract][Full Text] [Related]
17. Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition.
Maslah N; Verger E; Giraudier S; Chea M; Hoffman R; Mascarenhas J; Cassinat B; Kiladjian JJ
Blood Adv; 2022 May; 6(9):2813-2823. PubMed ID: 35030630
[TBL] [Abstract][Full Text] [Related]
18. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.
Robinson C; Boyce AM; Estrada A; Kleiner DE; Mathew R; Stanton R; Frangoul H; Collins MT
Osteoporos Int; 2018 Jan; 29(1):237-241. PubMed ID: 29071359
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia.
Malcikova J; Stano-Kozubik K; Tichy B; Kantorova B; Pavlova S; Tom N; Radova L; Smardova J; Pardy F; Doubek M; Brychtova Y; Mraz M; Plevova K; Diviskova E; Oltova A; Mayer J; Pospisilova S; Trbusek M
Leukemia; 2015 Apr; 29(4):877-85. PubMed ID: 25287991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
